Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 07, 2016 08:00 ET | Source: Researchmoz Global Pvt Ltd

Global Diabetes and Obesity Drugs Market to reach $163.2 Billion by 2022 - Insulins and GPCRs Retain Commercial Prominence, While High Unmet Need Remains in Weight Loss Treatment: ResearchMoz

Albany, NY, Sept. 07, 2016 (GLOBE NEWSWIRE) -- Diabetes is a chronic metabolic disease characterized by hyperglycemia (high blood glucose levels) that results from defects in insulin secretion,...